Status:
WITHDRAWN
Spleen Transplant in Solid Organ Transplantation
Lead Sponsor:
University of Illinois at Chicago
Conditions:
Kidney Transplant Rejection
Positive FCXM (T or B Cell Positive)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Although the notions that kidney transplantation is the treatment of choice for patients with end-stage renal disease and that simultaneous kidney and pancreas transplant is the only treatment able to...
Detailed Description
Although the notions that kidney transplantation is the treatment of choice for patients with end-stage renal disease and that simultaneous kidney and pancreas transplant is the only treatment able to...
Eligibility Criteria
Inclusion
- Subjects must give written informed consent, and
- Subject is ≥ 18 years of age, and
- Subject is eligible for a kidney or simulateous kidney pancreas transplant, and
- Subjects are highly sensitized (cPRA 98-100%), and
- Subjects have a positive T flow crossmatch
Exclusion
- Severe cardiac disease not amenable to intervention
- Clinical significant systemic infection within 30 days prior to transplant
- Life expectancy \< 1 Year
- Positive pregnancy test performed \< 1 week prior to enrollment or intention to plan a pregnancy in the following year
- Current drug or alcohol abuse
- Uncontrolled, severe psychiatric illness
- Combined transplantation of kidney and other organs
Key Trial Info
Start Date :
March 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2026
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04827186
Start Date
March 26 2021
End Date
April 1 2026
Last Update
February 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60612